latest news on glp 1 drugs GLP-1 Agonists Weight Loss Market Report, 2025-2030 A new wave of weight-loss
Description
To overcome the rapid degradation of GLP-1, two approaches have been developed: 1) GLP-1 receptor agonists resistant to DPP-IV metabolism, and 2) DPP-IV inhibitors to augment the effect of native/endogenous GLP-1
This trend aligns with broader increases in GLP-1 RA utilization across the general population during the same period ( 15 )
Who Are Weight Loss Medications Not a Good Fit For
The patient reported dysphagia and belching, which were also present even before the initiation of semaglutide treatment, and these symptoms resolved spontaneously in the following months
Quddos F, Hubshman Z, Tegge A
